Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

25
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (14)

Searched Name

Kim Kirkwood

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Reynolds-Cowie P, Kirkwood K, O'Connor R. Post-ICU psychology support during the COVID-19 pandemic. Nurs Crit Care 2024. [PMID: 38733236 DOI: 10.1111/nicc.13087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 04/11/2024] [Accepted: 04/15/2024] [Indexed: 05/13/2024]

Abstract

BACKGROUND

Critical illness survival rates have improved, but patients frequently face prolonged new or worsened physical, cognitive and psychosocial impairments (Josepha op't Hoog et al., 2022, Aust Crit Care). These difficulties associated with critical care admission are known as post-intensive care syndrome (PICS).

AIMS

The multidisciplinary InS:PIRE programme was developed to support patients in the recovery period from critical illness. During the COVID-19 pandemic, the psychology support offered by this service was adapted from an in-person group to individual remote review. This audit evaluated both the extent to which this input aligned with the recommended guidelines and the acceptability of this adapted delivery to this patient group, which could help guide post-pandemic psychology input to the service.

STUDY DESIGN

The records of 207 patients were analysed retrospectively. The nature of support offered to a sub-sample of 50 patients detailed in clinical summary letters was compared with the Faculty of Intensive Care Medicine (2019) guidelines. Telephone calls were made to gather feedback on the virtual psychology support from 10 patients.

RESULTS

Psychological difficulties were identified by 111 of the 207 patients who attended the virtual clinic. A total of 88 of these patients accepted referral for virtual psychology support and 67 (76%) of those patients attended. The virtual psychology support offered was found to be largely in accordance with ICU aftercare guidance and acceptable to patients. Patients found the summary letters of consultations accurate and helpful. Most patients expressed a preference for in-person support and the opportunity to meet other patients.

CONCLUSIONS

The adaptations to the psychology support offered by InS:PIRE during the COVID-19 pandemic were found to be largely in line with ICU aftercare psychology guidelines and were acceptable to patients. Further research is needed on future methods of delivering psychology support for this patient group.

RELEVANCE TO CLINICAL PRACTICE

This audit highlights issues important to patients in the post-ICU period based on individual consultations not previously possible. Patient opinion was sought on the impact of changing the delivery of post-ICU psychological support, which will help guide future improvements in the service.

Collapse

Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF, Fong L, Nelson A, Kumar R, Lee J, Burra A, Hsu J, Hackett C, Tolentino K, Sjarif J, Johnson P, Shao E, Abrau D, Lupin L, Shaw C, Collins Z, Lea T, Corvera C, Nakakura E, Carnevale J, Alvarado M, Loo K, Chen L, Chow M, Grandis J, Ryan W, El-Sayed I, Jablons D, Woodard G, Meng MW, Porten SP, Okada H, Tempero M, Ko A, Kirkwood K, Vandenberg S, Guevarra D, Oropeza E, Cyr C, Glenn P, Bolen J, Morton A, Eckalbar W. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell 2022;185:184-203.e19. [PMID: 34963056 PMCID: PMC8862608 DOI: 10.1016/j.cell.2021.12.004] [Citation(s) in RCA: 58] [Impact Index Per Article: 29.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 08/25/2021] [Accepted: 12/03/2021] [Indexed: 01/09/2023]

Affiliation(s)

Alexis J. Combes Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA,&Correspondence: and
Bushra Samad Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Jessica Tsui Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Nayvin W. Chew Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Peter Yan Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Gabriella C. Reeder Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Divyashree Kushnoor Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Alan Shen Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Brittany Davidson ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Andrea J. Barczak UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Michael Adkisson UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Austin Edwards Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Mohammad Naser Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Kevin C. Barry Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Tristan Courau Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Taymour Hammoudi Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Rafael J Argüello Aix Marseille University, CNRS, INSERM, CIML, Centre d’Immunologie de Marseille-Luminy, Marseille, FRANCE
Arjun Arkal Rao Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Adam B. Olshen UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,7Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA,8Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94143, USA
The Immunoprofiler consortium
Cathy Cai Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Jenny Zhan Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Katelyn C. Davis Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA
Robin K. Kelley Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA
Jocelyn S. Chapman UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,9Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, University of California San Francisco, San Francisco, CA 94143, USA
Chloe E. Atreya UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,7Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA,10Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143, USA
Amar Patel UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,10Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143, USA
Adil I. Daud Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143, USA,11Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA
Patrick Ha Department of Otolaryngology, University of California San Francisco, San Francisco, CA 94143, USA
Aaron A. Diaz Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA
Johannes R. Kratz ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,14Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
Eric A. Collisson UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,7Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA,10Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143, USA
Gabriela K Fragiadakis ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA,15Department of Medicine Division of Rheumatology, University of California San Francisco, San Francisco, CA 94143, USA
David J. Erle ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,4UCSF CoLabs, University of California San Francisco, San Francisco, CA 94143, USA,16Lung Biology Center, Department of Medicine and the Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA 94143, USA
Alexandre Boissonnas Sorbonne Université, INSERM, CNRS, Centre d’Immunologie et des Maladies Infectieuses - CIMI, Paris, France
Saurabh Asthana UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,8Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94143, USA
Vincent Chan ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,18Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA
Matthew F. Krummel Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA,2ImmunoX Initiative, University of California San Francisco, San Francisco, CA 94143, USA,3UCSF Immunoprofiler Initiative, University of California San Francisco, San Francisco, CA 94143, USA,&Correspondence: and
Lawrence Fong
Amanda Nelson
Raj Kumar
Justin Lee
Arun Burra
Joy Hsu
Caroline Hackett
Karen Tolentino
Jasmine Sjarif
Peter Johnson
Evans Shao
Darrell Abrau
Leonard Lupin
Cole Shaw
Zachary Collins
Tasha Lea
Carlos Corvera
Eric Nakakura
Julia Carnevale
Michael Alvarado
Kimberley Loo
Lawrence Chen
Melissa Chow
Jennifer Grandis
Will Ryan
Ivan El-Sayed
David Jablons
Gavitt Woodard
Maxwell W. Meng
Sima P. Porten
Hideho Okada
Margaret Tempero
Andrew Ko
Kim Kirkwood
Scott Vandenberg
Denise Guevarra
Erica Oropeza
Chris Cyr
Pat Glenn
Jennifer Bolen
Amanda Morton
Walter Eckalbar

Collapse

Roberts NJ, Kidd L, Kirkwood K, Cross J, Partridge MR. How is the education component of pulmonary rehabilitation delivered in practice--Is it patient-centred? Clin Respir J 2021;15:835-842. [PMID: 33825323 DOI: 10.1111/crj.13371] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Accepted: 04/01/2021] [Indexed: 11/28/2022]

Cuschieri K, Pan J, O Donnell M, Kirkwood K, Kavanagh K, Pollock KG, Bhatia R, Graham SV, Wakeham K. Penile cancer and the HPV attributable fraction in Scotland; A retrospective cohort study. J Clin Virol 2020;134:104717. [PMID: 33360857 DOI: 10.1016/j.jcv.2020.104717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Revised: 12/07/2020] [Accepted: 12/09/2020] [Indexed: 10/22/2022]

Tindell A, Kerrigan S, Gallacher M, Straiton K, Everitt P, Campbell F, Chrystal A, Wilson H, Kirkwood K, Siebert S. 266 Patient health questionnaire-4 screening and its composite domains indicate high levels of anxiety and depression in patients with psoriatic arthritis and are not predicted by other patient factors. Rheumatology (Oxford) 2019. [DOI: 10.1093/rheumatology/kez107.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open

Roberts NJ, Kidd L, Kirkwood K, Cross J, Partridge MR. A systematic review of the content and delivery of education in pulmonary rehabilitation programmes. Respir Med 2018;145:161-181. [PMID: 30509706 DOI: 10.1016/j.rmed.2018.11.002] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 11/01/2018] [Accepted: 11/02/2018] [Indexed: 11/26/2022]

Lin C, Bruinooge S, Kirkwood K, Hershman D, Jemal A, Yu J, Guadagnolo B, Hopkins S, Goldstein M, Bajorin D, Giordano S, Kosty M, Arnone A, Hanley A, Stevens S, Olsen C. Association Between Geographic Access and Receipt of Radiation Therapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1484] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]

Meeuse B, Schneider E, Hess C, Kirkwood K, Patt JM. ACTIVATION AND POSSIBLE ROLE OF THE “FOOD-BODIES” OF SAUROMATUM (ARACEAE). ACTA ACUST UNITED AC 2015. [DOI: 10.1111/j.1438-8677.1984.tb01840.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]

Cattaruzza F, Amadesi S, Carlsson JF, Murphy JE, Lyo V, Kirkwood K, Cottrell GS, Bogyo M, Knecht W, Bunnett NW. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants. Br J Pharmacol 2015;171:3814-26. [PMID: 24749982 DOI: 10.1111/bph.12738] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2013] [Revised: 03/26/2014] [Accepted: 04/11/2014] [Indexed: 01/04/2023] Open

Abstract

BACKGROUND AND PURPOSE

Although serine proteases and agonists of protease-activated receptor 2 (PAR2) cause inflammation and pain, the spectrum of proteases that are activated by proinflammatory and algesic stimuli and their contribution to inflammatory pain are uncertain.

EXPERIMENTAL APPROACH

Enzymic assays and selective inhibitors were used to characterize protease activity in mice after intraplantar injections of formalin, bradykinin, PAR2 activating peptide (AP) or vehicle. The capacity of these proteases and of recombinant mouse trypsin 4 to cleave fragments of PAR2 and to activate PAR2 in cell lines was determined. Protease inhibitors and par2 (-/-) mice were used to assess the contributions of proteases and PAR2 to pain and inflammation.

KEY RESULTS

Intraplantar injection of formalin, bradykinin or PAR2-AP led to the activation of proteases that were susceptible to the serine protease inhibitor melagatran but resistant to soybean trypsin inhibitor (SBTI). Melagatran inhibited mouse trypsin 4, which degraded SBTI. Proteases generated in inflamed tissues cleaved PAR2-derived peptides. These proteases and trypsin 4 increased [Ca(2+) ]i in PAR2-transfected but not in untransfected cells, and melagatran suppressed this activity. Melagatran or PAR2 deletion suppressed oedema and mechanical hypersensitivity induced by intraplantar formalin, bradykinin and PAR2-AP, but had no effect on capsaicin-induced pain.

CONCLUSIONS AND IMPLICATIONS

Diverse proinflammatory and algesic agents activate melagatran-sensitive serine proteases that cause inflammation and pain by a PAR2-mediated mechanism. By inducing self-activating proteases, PAR2 amplifies and sustains inflammation and pain. Serine protease inhibitors can attenuate the inflammatory and algesic effects of diverse stimuli, representing a useful therapeutic strategy.

Collapse

Cassidy S, Turnbull S, Gardani M, Kirkwood K. Attendance at pulmonary rehabilitation classes. Chron Respir Dis 2014;11:95-102. [DOI: 10.1177/1479972314527469] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open

Kubat E, Lyo V, Liao M, Kirkwood K, Bhargava A. De Novo Expression Of Urocortin 1 In Acinar Cells: Urocortin 1 Exerts Inflammatory Effect Via CRF-R2 During Pancreatitis. J Surg Res 2011. [DOI: 10.1016/j.jss.2010.11.405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]

Kirkwood K. In the name of the greater good? Emerging Health Threats Journal 2009. [DOI: 10.3402/ehtj.v2i0.7092] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]

Kirkwood K. In the name of the greater good? Emerg Health Threats J 2009;2:e12. [PMID: 22460282 PMCID: PMC3167651 DOI: 10.3134/ehtj.09.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/20/2009] [Revised: 10/30/2009] [Accepted: 11/09/2009] [Indexed: 11/18/2022]

Ceppa E, Grahn S, Divino L, Kirkwood K. P51. J Surg Res 2007. [DOI: 10.1016/j.jss.2006.12.280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Keller PA, Kirkwood K, Morgan J, Westcott S, McCluskey A. The prevention of preterm labour -- corticotropin releasing hormone type 1 receptors as a target for drug design and development. Mini Rev Med Chem 2003;3:295-303. [PMID: 12678823 DOI: 10.2174/1389557033488105] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]

Freir V, Kirkwood K, Peck D, Robertson S, Scott-Lodge L, Zeffert S. Telemedicine for clinical psychology in the Highlands of Scotland. J Telemed Telecare 2000;5:157-61. [PMID: 10628030 DOI: 10.1258/1357633991933567] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]

Greenwald RA, Kirkwood K. Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Rheumatol 1999;26:1650-3. [PMID: 10451056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]

Kirkwood K, Horn K, Glasier A, Sutherland S, Young H, Patrizio C. Non-invasive screening of teenagers for Chlamydia trachomatis in a family planning setting. Br J Fam Plann 1999;25:11-2. [PMID: 10228243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]

Coplan J, Contello KA, Cunningham CK, Weiner LB, Dye TD, Roberge L, Wojtowycz MA, Kirkwood K. Early language development in children exposed to or infected with human immunodeficiency virus. Pediatrics 1998;102:e8. [PMID: 9651460 DOI: 10.1542/peds.102.1.e8] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open

Abstract

OBJECTIVES

To compare language development in infants and young children with human immunodeficiency virus (HIV) infection to language development in children who had been exposed to HIV but were uninfected, and (among subjects with HIV infection) to compare language development with cognitive and neurologic status.

DESIGN

Prospective evaluation of language development in infected and in exposed but uninfected infants and young children.

SETTING

Pediatric Infectious Disease Clinic, State University of New York-Health Science Center at Syracuse.

SUBJECTS

Nine infants and young children infected with HIV and 69 seropositive but uninfected infants and children, age 6 weeks to 45 months.

RESULTS

Mean Early Language Milestone Scale, 2nd edition (ELM-2) Global Language scores were significantly lower for subjects with HIV infection, compared with uninfected subjects (89.3 vs 96.2, Mann-Whitney U test). The proportion of subjects scoring >2 SD below the mean on the ELM-2 on at least one occasion also was significantly greater for subjects with HIV infection, compared with uninfected subjects (4 of 9 infected subjects, but only 5 of 69 uninfected subjects; Fisher's exact test). Seven of the 9 subjects with HIV infection manifested deterioration of language function. Four manifested unremitting deterioration; only 1 of these 4 demonstrated unequivocal abnormality on neurologic examination. Three subjects with HIV infection and language deterioration showed improvement in language almost immediately after the initiation of antiretroviral drug treatment. Magnetic resonance imaging or computed tomography of the brain were performed in 6 of 7 infected subjects with language deterioration, and findings were normal in all 6. ELM-2 Global Language scaled scores showed good agreement with the Bayley Mental Developmental Index or the McCarthy Global Cognitive Index (r = 0. 70). Language deterioration, or improvement in language after initiation of drug therapy, coincided with or preceded changes in global cognitive function, at times by intervals of up to 12 months.

CONCLUSIONS

Language deterioration occurs commonly in infants and young children with HIV infection, is seen frequently in the absence of abnormalities on neurologic examination or central nervous system imaging, and may precede evidence of deterioration in global cognitive ability. Periodic assessment of language development should be added to the developmental monitoring of infants and young children with HIV infection as a means of monitoring disease progression and the efficacy of drug treatment.

Collapse

Kirkwood K, Peck D. How do you identify people with severe mental illness in rural communities? Ment Health Care 1997;1:61-3. [PMID: 9400211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]

Figini M, Emanueli C, Grady EF, Kirkwood K, Payan DG, Ansel J, Gerard C, Geppetti P, Bunnett N. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol 1997;272:G785-93. [PMID: 9142909 DOI: 10.1152/ajpgi.1997.272.4.g785] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

Coplan J, Dye TD, Contello KA, Cunningham CK, Kirkwood K, Weiner LB. Failure to identify human immunodeficiency virus-seropositive newborns: epidemiology and enrollment patterns in a predominantly white, nonurban setting. Pediatrics 1995;96:1083-9. [PMID: 7491225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open

Abstract

OBJECTIVE

To describe the epidemiology of newborn seroprevalence for human immunodeficiency virus (HIV) in a predominantly white, nonurban population, and to determine the factors associated with enrollment at a regional pediatric acquired immunodeficiency syndrome (AIDS) center serving that population.

DESIGN

Retrospective case series of children enrolled at a regional pediatric AIDS center during a 6-year period and comparison with universal blind newborn screening data collected by the state of New York during the same time interval.

SETTING

The Pediatric AIDS Center at State University of New York-Health Science Center at Syracuse, which serves as the only source of HIV-related pediatric care for children in a 16-country region of upstate New York totaling 1.8 million population.

RESULTS

One hundred thirty-nine HIV-seropositive infants were born in the region during the 6-year study period; complete blind screening data were available for 138. Sixty-five (47%) of these infants were white. Thirty-nine (28%) of 138 had been enrolled at the Pediatric AIDS Center within the first 90 days of life. An additional 22 (16%) were enrolled at older than 90 days of life. The remaining 77 (56%) have never been seen at the center and are presumed to be unidentified. County enrollment rates varied from 0% to 100% and correlated with percent nonwhite births (r = .58; 95% confidence interval, 0.04-0.86). Children in outlying counties were at greater risk for nonenrollment than children from Onondaga County (site of the Pediatric AIDS Center) (adjusted relative risk, 1.38; 95% confidence interval, 1.05-1.85). White infants residing outside of Onondaga County were at the greatest risk of nonenrollment; of 50 seropositive white infants residing outside of Onondaga County, only 7 (14%) were enrolled at the center within the first 90 days of life.

CONCLUSIONS

Local demographic factors can skew the racial distribution of HIV-seropositive infants dramatically compared with the national experience. White race and residence in counties away from the medical center each constituted risk factors for nonenrollment at the Pediatric AIDS Center. The epidemiology of HIV in this predominantly white, rural population, coupled with physician practices, probably contributed to low identification and enrollment rates. As the AIDS epidemic spreads into similar populations elsewhere, HIV infection in pregnant women or newborn infants is likely to become progressively harder to detect, unless universal screening is adopted.

Collapse

Crawford JR, Besson JA, Bremner M, Ebmeier KP, Cochrane RH, Kirkwood K. Estimation of premorbid intelligence in schizophrenia. Br J Psychiatry 1992;161:69-74. [PMID: 1638332 DOI: 10.1192/bjp.161.1.69] [Citation(s) in RCA: 76] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]

Guttmann RD, McIntyre C, Poulsen RS, Kirkwood K, Pshyk K, Jean R, Frei D. Effect of blood transfusion on the development of cytotoxic antibody and immunoregulatory lymphocyte subsets enumerated by monoclonal antibodies and FACS analysis. Transplant Proc 1982;14:344-6. [PMID: 7051475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]

Rao BN, Shaw HC, Kirkwood K. Thymic cyst of the neck. W INDIAN MED J 1981;30:43-6. [PMID: 7269551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]